- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01950546
Nanosilver Fluoride to Prevent Dental Biofilms Growth (NSFCT)
June 8, 2015 updated by: Priscila Lima de Luna Freire, University of Pernambuco
Nanosilver Fluoride: a Microbiological and Clinical Trial
This study aims to evaluate the effectiveness of nanosilver fluoride for controlling the growth of S. mutans present in dental plaque of children.
Study Overview
Detailed Description
The product will be apllied on cervical vestibular surfaces of incisors and canines healthy, with a total of 8 teeth, 4 upper and 4 below.
Children will be instructed not to ingest any liquid or food within two hours after application.
After a period of 7 days will be carried biofilm colect of cervical dental surfaces of incisors and / or canines upper and lower, with the aid of sterile spatulas.
This material will be packaged in pre-weighed microfuge tubes containing 1.5 ml of buffered saline solution (0.9% sodium chloride), and transported under refrigeration immediately to the laboratory where analysis will be performed and the S. mutans colonies will be counted.
The biofilm collect and posterior laboratorial analysis will be performed weekly.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Paraíba
-
João Pessoa, Paraíba, Brazil, 58046020
- Escola Municipal Anita Trigueiro do Valle
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 year to 2 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Have at least 4 upper teeth and 4 lower teeth deciduous;systemic health satisfactory; did not use antibiotics or nonsteroidal anti-inflammatory within one month before or during the study;do not use any other forms of chemical control of biofilm during the study period;not being a user of orthodontic devices or dentures;
Exclusion Criteria:
- Presenting oral lesions, supragingival calculus and severe malocclusion.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Nanosilver fluoride
This product is a solution composed of: 390 mg / ml 9nm silver nanoparticles ;21 mg / ml chitosan ; 22 mg / ml NaF.The cariostatic agent, nanosilver fluoride, was formulated in a similar way to silver diamine fluoride, so that this new formulation contained 5% nanosilver fluoride, while commercial diamine silver fluoride contains 30% silver fluoride.
It will be applied once with a microbrush on tooth surfaces to check if it prevents the growth of S. mutans biofilms on dental surfaces.
|
The product will be applied in the volunteers in the morning, before the first class, in relative isolation, made with cotton rolls and Vaseline to protect the soft tissue.
It will apply 30mg of the product with microbrush, previously standardized in a pilot study on cervical vestibular surfaces of incisors and canines healthy, on a total of 8 teeth, 4 upper and 4 lower.
After a period of 7 days,the cervical dental biofilms will be collect, third on the buccal surfaces of incisors and / or canines upper and lower, with the aid of sterile spatulas.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Initial biofilm collecting before applying the product and after nanosilver fluoride application.
Time Frame: one week
|
The initial dental biofilm collection will be conducted to count colony-forming units of S. mutans and then the product will be applied on these dental surfaces after the collect.
After one week, a new collect will be performed and the colony-forming units of S. mutans will be counting to compare with the initial.
|
one week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of effectiveness of nanosilver fluoride on bacterial growth in the dental biofilm
Time Frame: two weeks
|
Collection of dental biofilm will be performed after two weeks of product application and colony count will be performed in the laboratory.
|
two weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Collection of dental biofilm will after four weeks of product application.
Time Frame: Four weeks
|
Collection of dental biofilm will be performed after four weeks of product application and colony count will be performed in the laboratory.
|
Four weeks
|
|
Collection of dental biofilm after eight weeks of product application
Time Frame: Eight weeks
|
Collection of dental biofilm will be performed after eight weeks of product application and will be compared with the initial score of S. mutans colony forming units.
|
Eight weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Aronita Rosenblatt, PhD, UPE
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2014
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
January 1, 2015
Study Registration Dates
First Submitted
September 16, 2013
First Submitted That Met QC Criteria
September 21, 2013
First Posted (Estimate)
September 25, 2013
Study Record Updates
Last Update Posted (Estimate)
June 10, 2015
Last Update Submitted That Met QC Criteria
June 8, 2015
Last Verified
June 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FOP01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Caries
-
National University of San Marcos, PeruNot yet recruitingPit and Fissure Caries | Caries,Dental | Sealant DentalPeru
-
Ain Shams UniversityCompletedPulpitis | Caries | Caries,Dental | Reversible Pulpitis | Caries Class I | Caries; DentinEgypt
-
University of MinnesotaCompletedUsing Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood CariesCaries | Caries,DentalUnited States
-
Future University in EgyptNot yet recruitingDeep Caries | Caries, Dental
-
Federal University of PelotasRecruiting
-
Kompetansesenteret Tannhelse Midt (TkMidt)Karolinska Institutet; University of Bergen; Norwegian University of Science... and other collaboratorsActive, not recruiting
-
Marmara UniversityCompleted
-
Suez Canal UniversityCompleted
-
Pomeranian Medical University SzczecinCompleted
-
Rawda Hesham Abd ElAzizRecruitingCaries,Dental | Caries Class IIEgypt
Clinical Trials on nanosilver fluoride
-
Nour Ammar, BDSTerminatedDental Caries in Children | Microbial Colonization | Caries | Primary TeethEgypt
-
Alexandria UniversityCompletedEarly Childhood CariesEgypt
-
Alexandria UniversityCompletedHypersensitivity | Molar Incisor HypomineralizationEgypt
-
University of BaghdadRecruiting
-
Hams Hamed AbdelrahmanRecruitingWhite Spot LesionEgypt
-
October University for Modern Sciences and ArtsNot yet recruitingEarly Childhood Caries (ECC) | Active Dentin Caries in Primary MolarsEgypt
-
Assiut UniversityRecruiting
-
Cairo UniversityNot yet recruiting
-
Church & Dwight Company, Inc.CompletedOral Malodor (Halitosis)United States
-
Ivoclar Vivadent AGNot yet recruitingDentin Hypersensitivity | Dentin Desensitizing AgentsLiechtenstein